SinoMab Bioscience Ltd.'s total assets for Q4 2025 were ¥908.50M, an increase of 25.81% from the previous quarter. HK:3681 total liabilities were ¥400.41M for the fiscal quarter, a -16.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.